Compositions for the in vivo delivery of RNAi agents
US8900627B2 · kind B2 · utility
4Cited by
28References
29Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 5, 2009 |
| Grant date | Dec 2, 2014 |
| Priority date | — |
| Expiry date | Dec 31, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/19
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application describes emulsion formulations containing neutral phospholipids for delivering RNAi, anti-miRNA, or aptamer agents in vivo. The application also relates to methods of making the formulations, and uses of the formulations as delivery agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.